Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
DrugCendR
Scientific Title
A Phase 1 Clinical Trial of CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Exocrine Pancreatic Cancer